← Back to headlines
Circio Raises $65 Million in H1 2026 Amid Gene Therapy Pipeline Progress
Biotechnology firm Circio secured $65 million in funding during the first half of 2026, coinciding with promising clinical data showing a 60-fold boost in its gene therapy approach.
1 Sept, 09:23 — 1 Sept, 09:23
Sources
Showing 1 of 1 sources
